Michael J Corbel

Summary

Affiliation: Health Protection Agency
Country: UK

Publications

  1. doi Vaccines and biosimilarity: a solution or a problem?
    Michael J Corbel
    Division of Bacteriology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, EN6 3QG, UK
    Expert Rev Vaccines 8:1439-49. 2009
  2. doi Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains
    Mei M Ho
    Bacteriology Division, NIBSC HPA, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 29:512-8. 2011
  3. doi Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine
    Kevin Markey
    Bacteriology Division, NIBSC HPA, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 28:6964-9. 2010
  4. ncbi A retrospective study on the quality of Haemophilus influenzae type b vaccines used in the UK between 1996 and 2004
    Barbara Bolgiano
    Bacteriology Division, National Institute for Biological Standards and Control, Hertfordshire, UK
    Hum Vaccin 3:176-82. 2007
  5. ncbi Transferability of dermal temperature histamine sensitization test for estimation of pertussis toxin activity in vaccines
    Rose Gaines-Das
    Biostatistics Department, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK
    Hum Vaccin 5:166-71. 2009
  6. doi Current progress with Moraxella catarrhalis antigens as vaccine candidates
    Fatme Mawas
    Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN63QG, UK
    Expert Rev Vaccines 8:77-90. 2009
  7. doi Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine
    Mei M Ho
    Bacteriology Division, NIBSC, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 26:4754-7. 2008
  8. ncbi Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis
    Fatme Mawas
    Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 25:4801-8. 2007
  9. doi WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland
    Michael J Corbel
    National Institute for Biological Standards and Control, UK
    Vaccine 26:1913-21. 2008

Collaborators

Detail Information

Publications9

  1. doi Vaccines and biosimilarity: a solution or a problem?
    Michael J Corbel
    Division of Bacteriology, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, EN6 3QG, UK
    Expert Rev Vaccines 8:1439-49. 2009
    ..The need for an acceptable definition of biosimilarity and guidelines relevant to vaccines is emphasized...
  2. doi Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains
    Mei M Ho
    Bacteriology Division, NIBSC HPA, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 29:512-8. 2011
    ..The proposal for the establishment of these First WHO Reference Reagents for BCG vaccines was discussed in the WHO Expert Committee on Biological Standardization meeting, October 2009...
  3. doi Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine
    Kevin Markey
    Bacteriology Division, NIBSC HPA, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 28:6964-9. 2010
    ..The majority of the participants in the study generated the expected PCR product profiles indicating the method is also robust...
  4. ncbi A retrospective study on the quality of Haemophilus influenzae type b vaccines used in the UK between 1996 and 2004
    Barbara Bolgiano
    Bacteriology Division, National Institute for Biological Standards and Control, Hertfordshire, UK
    Hum Vaccin 3:176-82. 2007
    ....
  5. ncbi Transferability of dermal temperature histamine sensitization test for estimation of pertussis toxin activity in vaccines
    Rose Gaines-Das
    Biostatistics Department, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, UK
    Hum Vaccin 5:166-71. 2009
    ....
  6. doi Current progress with Moraxella catarrhalis antigens as vaccine candidates
    Fatme Mawas
    Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN63QG, UK
    Expert Rev Vaccines 8:77-90. 2009
    ..Regulatory issues surrounding vaccines of this type are also discussed...
  7. doi Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine
    Mei M Ho
    Bacteriology Division, NIBSC, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 26:4754-7. 2008
    ..A collaborative study will be carried out using this modified ATP assay in parallel with the cultural viable count method in the establishment of the replacement of the WHO International Reference Preparation of BCG vaccine...
  8. ncbi Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis
    Fatme Mawas
    Division of Bacteriology, National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Potters Bar, Hertfordshire EN6 3QG, UK
    Vaccine 25:4801-8. 2007
    ....
  9. doi WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland
    Michael J Corbel
    National Institute for Biological Standards and Control, UK
    Vaccine 26:1913-21. 2008
    ..The working group was met again to review the first drafts and to input further suggestions or amendments to the contributions of the drafting groups. The revised manual was to be finalized and published by WHO...